MARISA REESE: Open Payments
NPI 1689009573 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 53 payments from 17 companies in 2025. Trend: 2023 $616 · 2024 $841 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $172 |
| Amgen Inc. | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Novo Nordisk Inc | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| ABBVIE INC. | 3 | $42 |
| Dexcom, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $35 |
Products named: NURTEC ODT, XIFAXAN, AIRSUPRA, PREVNAR 20, Kerendia, Wegovy, Dexcom G6 Transmitter, Veozah.
Industry payments across KS — which companies pay providers there.
